Talis Biomedical Corporation Shareholders' Equity
Talis Biomedical Corporation had Shareholders' Equity of $48.63 million as of 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-08-19
- 2024-06-30: Stockholders' Equity Attributable to Parent $48.63M.
- 2024-03-31: Stockholders' Equity Attributable to Parent $56.68M.
- 2023-12-31: Stockholders' Equity Attributable to Parent $69.12M.
- 2023-09-30: Stockholders' Equity Attributable to Parent $81.56M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2024-06-30 | $48.63M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $56.68M 10-Q · filed 2024-08-19 |
| 2023-12-31 | $69.12M 10-Q · filed 2024-08-19 |
| 2023-09-30 | $81.56M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $96.17M 10-Q · filed 2024-08-19 |
| 2023-03-31 | $110.12M 10-Q · filed 2024-08-19 |
| 2022-12-31 | $126.74M 10-Q · filed 2024-08-19 |
| 2022-09-30 | $152.39M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $177.02M 10-Q · filed 2023-11-14 |
| 2022-03-31 | $202.78M 10-Q · filed 2023-11-14 |
| 2021-12-31 | $233.98M 10-K · filed 2024-03-28 |
| 2021-09-30 | $258.79M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $293.73M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $356.33M 10-Q · filed 2022-11-03 |
| 2020-12-31 | -$108.57M 10-K · filed 2023-03-22 |
| 2020-09-30 | -$65.94M 10-Q · filed 2021-11-16 |
| 2020-06-30 | -$37.47M 10-Q · filed 2021-11-16 |
| 2020-03-31 | -$27.83M 10-Q · filed 2021-11-16 |
| 2019-12-31 | -$21.14M 10-K · filed 2022-03-15 |